Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates.

The in vitro activities of three new quinolones (sparfloxacin, CI-960, and PD 131,628) were compared with that of ciprofloxacin against 5,252 routine clinical aerobic and facultatively anaerobic bacterial isolates. Overall, CI-960 was the most active drug in vitro (MIC for 90% of the strains tested,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Fuchs, P C, Barry, A L, Pfaller, M A, Allen, S D, Gerlach, E H
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 1991
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245095/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2069384/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.4.764
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki